Sector Update: Health Care

By
A A A

Health-care shares were flat to higher in pre-market trade Wednesday.

In health-care stocks news, GlaxoSmithKline Plc ( GSK ) fell in pre-market trading after cutting its 2014 outlook following slower Q2 sales.

The drugmaker reported Q2 earnings of 19.1 pence per share, missing the consensus forecast of 21.3 pence measured by Thomson Reuters. Sales of 5.56 billion pounds ($9.48 billion) missed the Wall Street forecast of 5.76 billion pounds as measured by Capital IQ.

And, Natus Medical ( BABY ) has announced Q2 results that beat analyst predictions on both EPS and total revenues. The company has also increased full-year guidance, fueled by strong performance in the neurology and newborn care segments and the launch of hearing screening service.

The healthcare product provider reported Q2 EPS of $0.28 per diluted share, up from $0.21 in Q2 2013 and

beating analyst estimates of $0.26. The company reported revenue of $86.3 million, up from $82.3 million in Q2 2013 and topping analyst projections of $84.85 million.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: GSK , BABY

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

106,679,460
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com